Clincosm LogoSign in Get a demo

Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04196972
Collaborator
National Cancer Institute (NCI) (NIH)
36
Enrollment
1
Location
2
Arms
40.5
Anticipated Duration (Months)
0.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This trial studies how well the Extension for Community Healthcare Outcomes (ECHO) telementoring intervention works in transforming professional engagement, practice efficiency, and community building through team meetings in diagnostic imaging clinicians. This study may help researchers learn more about the potential benefits of a model for team meetings aimed at bringing physicians together from multiple practice locations when few opportunities exist for meaningful, collegial interactions. It may also help diagnostic imaging clinicians engage more effectively with colleagues at distant sites and become more engaged with their work.

Condition or Disease Intervention/Treatment Phase
  • Other: Communication Intervention
  • Other: Questionnaire Administration
  • Other: Waiting List
 N/A

Detailed Description

PRIMARY OBJECTIVE:
  1. To determine the feasibility of the proposed anti-burnout intervention for faculty at MD Anderson, defined as at least 35/50 of participants each attending at least 9 out of 13 sessions.
SECONDARY OBJECTIVES:

  1. To explore any changes in burnout, measured by the Maslach Burnout Inventory (MBI) and Mini-Z surveys.

  2. To explore any changes in the self-reported health status of participants, as measured by the RAND Short-Form 36 (SF36) survey.

  3. To understand participants' perception of the benefits and usefulness of the intervention, measured by the customized Globalized Perception/Impression of Benefits Survey.

  4. To define methods for improving the intervention, based on participants' feedback following each session.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM A: Participants attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.

ARM B: Participants are placed on a wait-list for 13 weeks and then attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Transforming Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in a Telementoring Environment
Actual Study Start Date :
Aug 16, 2020
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm A (ECHO telementoring)

Participants attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.

Other: Communication Intervention
Receive ECHO telementoring intervention

Other: Questionnaire Administration
Ancillary studies
Experimental: Arm B (wait-list, ECHO telementoring)

Participants are placed on a wait-list for 13 weeks and then attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.

Other: Communication Intervention
Receive ECHO telementoring intervention

Other: Questionnaire Administration
Ancillary studies

Other: Waiting List
Placed on wait-list
Other Names:
  • Waitlist

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Proportion of sessions attended [through study completion, an average of 1 year]

      Will be evaluated by attendance records for each session. Will estimate the attendance rate (p = proportion of participants attending at least 9 out of 13 sessions) with 95% confidence intervals.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Faculty must be diagnostic imaging clinicians with a primary appointment in the Division of Diagnostic Imaging at MD Anderson
    Exclusion Criteria:

    • Faculty that have an official leadership role (Division Head or Department Chair)

    • Faculty that have previously participated in any previous live ECHO clinic or ECHO activity

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 M D Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • M.D. Anderson Cancer Center
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Eduardo Bruera, M.D. Anderson Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    M.D. Anderson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT04196972
    Other Study ID Numbers:
    • 2019-0639
    • NCI-2019-07565
    • 2019-0639
    First Posted:
    Dec 12, 2019
    Last Update Posted:
    Jun 1, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Neoplasms

    Study Results

    No Results Posted as of Jun 1, 2022